Dave S.�B. Hoon

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Abstract 1064: Novel approach of single-cell RNAseq analysis to assess cancer cells in prostate core biopsy specimens

  Cancer Research · 2026-04-03

• Abstract 5321: Comprehensive profiling of urine microRNAs in prostate cancer patients.

  Cancer Research · 2026-04-03

• Interferon-gamma (IFN-gamma)-inducible protein 30 regulates the IFN-gamma pathway activation and PD-L1 levels in metastatic melanoma to determine immunotherapy responses 9092

  The Journal of Immunology · 2025-11-01

• 455 Treg-associated ICOS as a possible biomarker for PD-1 therapy resistance in melanoma patients

  Regular and Young Investigator Award Abstracts · 2025-11-01

• Profiles of Circulating MicroRNAs Associated with the Development of ESKD in Diabetes

  Journal of the American Society of Nephrology · 2025-10-01

• Clonal dynamics shaped by diverse drug-tolerant persister states in melanoma resistancePreprint

  bioRxiv (Cold Spring Harbor Laboratory) · 2025-09-19

• Correction: Natural killer cell infiltration in prostate cancers predict improved patient outcomes

  Prostate Cancer and Prostatic Diseases · 2025-08-12 · 1 citations

• Potential impact of non-exonuclease <i>POLE</i> and <i>POLD1</i> mutations on high and ultrahigh TMB across cancers.

  Journal of Clinical Oncology · 2025-05-28 · 2 citations

• Comprehensive characterization of interleukin-enhanced factor 2 (ILF2) in triple-negative breast cancer (TNBC).

  Journal of Clinical Oncology · 2025-05-28

• Facts and Hopes: Toward the Next Quantum Leap in Melanoma

  Clinical Cancer Research · 2025-05-23 · 4 citations

• Characterizing spatial immune architecture in metastatic melanoma using high-dimensional multiplex imaging

  Frontiers in Immunology · 2025-04-29 · 6 citations

• A heterodimer of hemoglobin identifies theranostic targets on brain‐metastasizing melanoma cells

  International Journal of Cancer · 2025-04-26

• Abstract 5929: High performance miRNA and mRNA signatures that in combination with serum PSA levels predict prostate cancer patients with lymph-node invasion

  Cancer Research · 2025-04-21

• Transcriptomic miRNA and mRNA signatures in primary prostate cancer that are associated with lymph‐node invasion

  Clinical and Translational Medicine · 2025-04-01 · 1 citations

• Multiomic Characterization of <i>RCC1</i> and <i>RCC2</i> Expression and Their Association With Molecular Alterations, Immune Phenotypes, and Cancer Outcomes

  JCO oncology advances. · 2025-03-01

• The Landscape of Gain and Loss of Function Mutations in MelanomaPreprint

  SSRN Electronic Journal · 2025-01-01

• Human Epidermal Growth Factor Receptor 2 Alterations and Prognostic Implications in All Subtypes of Breast Cancers

  JCO Precision Oncology · 2025-01-01 · 1 citations

• Correction: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/ FOXO1 pathway

  Clinical Epigenetics · 2024-12-27 · 1 citations

• Vimentin is a ubiquitination and degradation substrate of the ubiquitin ligase KPC1

  Biochemical and Biophysical Research Communications · 2024-12-20 · 4 citations

• Biomarkers For Melanoma

  2024-12-15